A critical breakthrough in cancer study is occurring with the use of nanobodies to reactivate mutated p53. This crucial malignant inhibitor protein is frequently lost in several kinds of cancer, resulting uncontrolled https://bookmark-template.com/story30167101/vhh-fragments-revive-the-p53-protein-the-potential-approach-for-cancer-management